TNDM
Tandem Diabetes CareFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
Tandem sustains strong t:slim X2/Control‑IQ adoption, expands recurring software revenue, and improves margins — driving >50% upside as adoption accelerates and investor confidence returns.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -20.2.
What can break
Regulatory setbacks, an adverse recall, or persistent margin pressure from pricing and reimbursement could erase current value and push shares substantially lower (~40%+ decline).
Momentum
7
Value
37
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $22.80 · Bull $33.17 · Bear $12.44
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $29.85
Why
Momentum7 · Δ7d +2.0
Value37 · Δ7d -0.0
Sentiment68 · Δ7d -20.2
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
7
26% active weight
Current posture
7d trendImproving
Δ7d
+2.0
Δ21d
-8.6
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
68
34% active weight
Current posture
7d trendSoftening
Δ7d
-20.2
Δ21d
-8.7
Why this grade
Composite grade F. Momentum 6.9 / Value 36.5 / Sentiment 67.7
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.24B
Beta
1.69
Shares Out
68.53M
P/E (TTM) · Derived
-5.9
P/S (TTM)
1.56
P/FCF (TTM) · Derived
-318.10
Rev YoY
+5.5%
EPS YoY
-84.8%
Gross Margin
+54.9%
Op Margin
-19.5%
Net Debt
$156.71M
Current Ratio
3.58
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology